Remove Clinical Trials Remove Medicine Remove Radiology Remove Trials
article thumbnail

Pilot and Feasibility Testing: The LIRE Example

Rethinking Clinical Trials

Jerry Jarvik, principal investigator of the LIRE Demonstration Project, discusses pilot and feasibility testing in pragmatic clinical trials.

Radiology 130
article thumbnail

The Utility of Liquid Biopsy in Oncology Clinical Trials

XTalks

Gleich, MD, FACS, Senior Vice President, Medical Department, and Dr. Christopher Huth, PhD, Senior Clinical Trial Manager, Clinical Trial Management. Liquid Biopsy Use in Oncology Clinical Trials. FoundationOne ® Liquid CDx (Foundation Medicine; end-to-end commercial provider).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

What will the 2023 drug discovery landscape look like?

Drug Discovery World

Virtual clinical trials ‘Virtual’ and ‘technology’ are concepts which are readily exchanged in this industry, but these are more than just buzzwords. The overall virtual clinical trials market is currently valued at $7.8 billion, with a projected growth of 14% per annum 1. We’ve shown that this type of model can work.

article thumbnail

Why I Fight | A message from Gary Fishbein, MD, MPH

Worldwide Clinical Trials

Join us as we celebrate cancer research awareness month and clinical trials awareness month. Where I trained at the University of Maryland, there was literally a bridge that connected the research labs to the clinic. As I think back to my time in college, I was very interested in the rights of human subjects on research trials.

article thumbnail

Rezzayo (Rezafungin) Becomes First New Treatment Option for Candidemia and Invasive Candidiasis in Over a Decade

XTalks

The first line of treatment for invasive candidiasis is a subset of antifungal medications called echinocandins, which includes caspofungin (brand name Cancidas), the drug that rezafungin was compared with in clinical trials. Once the fungus cannot synthesize β-(1, 3)-D-glucan, it undergoes osmotic instability and cell death.

article thumbnail

Bayer delivers on medical innovation fueling transformation of pharma business

The Pharma Data

Our leadership in cardiology, radiology and women’s health is recognized worldwide, and we are expanding our presence in oncology, working tirelessly to bring forward new approaches that can change the treatment paradigm for patients,” said Stefan Oelrich, Member of the Board of Management, Bayer AG and President of Bayer’s Pharmaceuticals Division.

article thumbnail

Low-dose radiotherapy combined with immunotherapy eradicates metastatic cancer in mice

Bioengineer

“In clinical trials, we tend to go with the maximum tolerable dose, the idea being that radiation kills the cancer and the more we give, the better. . “In clinical trials, we tend to go with the maximum tolerable dose, the idea being that radiation kills the cancer and the more we give, the better.